BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,092 filers reported holding BAXTER INTL INC in Q1 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $14,778,297 | +441.3% | 324,370 | +381.9% | 0.58% | +455.8% |
Q1 2023 | $2,730,175 | -72.2% | 67,312 | -44.8% | 0.10% | -71.7% |
Q3 2020 | $9,813,000 | -6.6% | 122,023 | 0.0% | 0.37% | -8.0% |
Q2 2020 | $10,506,000 | +33.2% | 122,023 | +25.6% | 0.40% | +12.0% |
Q1 2020 | $7,890,000 | -27.4% | 97,183 | -25.2% | 0.36% | -13.1% |
Q4 2019 | $10,869,000 | -24.7% | 129,983 | -21.2% | 0.41% | -34.8% |
Q3 2019 | $14,429,000 | -0.3% | 164,958 | -6.6% | 0.63% | +6.6% |
Q2 2019 | $14,472,000 | +29.3% | 176,698 | +28.4% | 0.59% | +29.9% |
Q1 2019 | $11,194,000 | +5.5% | 137,668 | -14.6% | 0.46% | +0.2% |
Q4 2018 | $10,612,000 | -5.7% | 161,233 | +10.4% | 0.45% | +11.3% |
Q3 2018 | $11,258,000 | +13.7% | 146,040 | +8.9% | 0.41% | +8.5% |
Q2 2018 | $9,904,000 | +281.1% | 134,124 | +235.6% | 0.38% | +272.3% |
Q1 2018 | $2,599,000 | -80.2% | 39,965 | -87.5% | 0.10% | -81.9% |
Q1 2016 | $13,129,000 | +7.7% | 319,600 | 0.0% | 0.56% | +26.2% |
Q4 2015 | $12,193,000 | +16.1% | 319,600 | 0.0% | 0.44% | +17.2% |
Q3 2015 | $10,499,000 | -53.0% | 319,600 | 0.0% | 0.38% | -53.4% |
Q2 2015 | $22,350,000 | +2.1% | 319,600 | 0.0% | 0.81% | -6.7% |
Q1 2015 | $21,893,000 | +329.1% | 319,600 | +311.5% | 0.87% | +52.6% |
Q3 2013 | $5,102,000 | -5.2% | 77,675 | 0.0% | 0.57% | -22.4% |
Q2 2013 | $5,381,000 | – | 77,675 | – | 0.73% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |